R. McCormack

620 total citations
10 papers, 500 citations indexed

About

R. McCormack is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Oncology. According to data from OpenAlex, R. McCormack has authored 10 papers receiving a total of 500 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 5 papers in Cancer Research and 3 papers in Oncology. Recurrent topics in R. McCormack's work include Lung Cancer Treatments and Mutations (8 papers), Cancer Genomics and Diagnostics (5 papers) and Lung Cancer Diagnosis and Treatment (3 papers). R. McCormack is often cited by papers focused on Lung Cancer Treatments and Mutations (8 papers), Cancer Genomics and Diagnostics (5 papers) and Lung Cancer Diagnosis and Treatment (3 papers). R. McCormack collaborates with scholars based in United Kingdom, Japan and Russia. R. McCormack's co-authors include Tsveta Milenkova, Gyula Ostoros, Alan Webster, Manuel Cobo, Tudor–Eliade Ciuleanu, Koichi Hagiwara, Genichiro Ishii, Miyako Satouchi, Kazuto Nishio and Tetsuya Mitsudomi and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Annals of Oncology.

In The Last Decade

R. McCormack

10 papers receiving 492 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. McCormack United Kingdom 7 396 285 213 120 42 10 500
Liana B. Guedes United States 13 436 1.1× 222 0.8× 216 1.0× 145 1.2× 90 2.1× 17 566
Farhat Ghaznawi United States 5 245 0.6× 224 0.8× 170 0.8× 173 1.4× 38 0.9× 10 437
Aurelio Castrellon United States 12 392 1.0× 429 1.5× 210 1.0× 102 0.8× 27 0.6× 34 655
Kunitoshi Tomii Japan 4 480 1.2× 389 1.4× 150 0.7× 269 2.2× 34 0.8× 7 658
Laura Schubert United States 6 282 0.7× 199 0.7× 156 0.7× 198 1.6× 58 1.4× 13 397
Stefania Kinspergher Italy 12 318 0.8× 227 0.8× 112 0.5× 97 0.8× 28 0.7× 36 428
Tahsin M. Khan United States 8 364 0.9× 344 1.2× 115 0.5× 275 2.3× 61 1.5× 23 604
Amanda C. Pawlak United States 4 423 1.1× 339 1.2× 144 0.7× 180 1.5× 62 1.5× 5 576
Marco Brugia Italy 12 128 0.3× 218 0.8× 100 0.5× 117 1.0× 32 0.8× 31 354
Johann Raats South Africa 9 280 0.7× 367 1.3× 83 0.4× 188 1.6× 101 2.4× 15 569

Countries citing papers authored by R. McCormack

Since Specialization
Citations

This map shows the geographic impact of R. McCormack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. McCormack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. McCormack more than expected).

Fields of papers citing papers by R. McCormack

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. McCormack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. McCormack. The network helps show where R. McCormack may publish in the future.

Co-authorship network of co-authors of R. McCormack

This figure shows the co-authorship network connecting the top 25 collaborators of R. McCormack. A scholar is included among the top collaborators of R. McCormack based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. McCormack. R. McCormack is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Normanno, Nicola, Heather A. Brown, Vincent Haddad, et al.. (2016). 580_PR: Clinical and demographic features that influence EGFR mutation detection in plasma from patients (pts) with aNSCLC: The ASSESS experience. Journal of Thoracic Oncology. 11(4). S151–S151. 4 indexed citations
2.
3.
4.
Ostoros, Gyula, Manuel Cobo, Tudor–Eliade Ciuleanu, et al.. (2013). First-line gefitinib in Caucasian EGFR mutation-positive NSCLC patients: a phase-IV, open-label, single-arm study. British Journal of Cancer. 110(1). 55–62. 322 indexed citations
5.
6.
Goto, Kōichi, Miyako Satouchi, Genichiro Ishii, et al.. (2012). An evaluation study of EGFR mutation tests utilized for non-small-cell lung cancer in the diagnostic setting. Annals of Oncology. 23(11). 2914–2919. 90 indexed citations
7.
Varella‐Garcia, Marileila, Gayle Marshall, R. McCormack, et al.. (2007). Role of EGFR but not HER2 or HER3 gene copy number in predicting sensitivity of head and neck squamous cell carcinoma (SCCHN) cell lines to EGFR tyrosine kinase inhibitors. Journal of Clinical Oncology. 25(18_suppl). 6063–6063. 1 indexed citations
8.
Speake, Georgina, Gayle Marshall, Judith Anderton, et al.. (2006). A pharmacological comparison of gefitinib (IRESSA) and erlotinib. 66. 890–890. 2 indexed citations
9.
McCormack, R., Alexander P. Maxwell, D. J. Carson, et al.. (2002). The IL12B 3′ untranslated region DNA polymorphism is not associated with early-onset type 1 diabetes. Genes and Immunity. 3(7). 433–435. 20 indexed citations
10.
McCormack, R., et al.. (2001). Possible association between CTLA4 DNA polymorphisms and early onset type 1 diabetes in a UK population. Genes and Immunity. 2(4). 233–235. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Liana B. Guedes Breakdown of academic impact, for papers by Farhat Ghaznawi Breakdown of academic impact, for papers by Aurelio Castrellon Breakdown of academic impact, for papers by Kunitoshi Tomii Breakdown of academic impact, for papers by Laura Schubert Breakdown of academic impact, for papers by Stefania Kinspergher Breakdown of academic impact, for papers by Tahsin M. Khan Breakdown of academic impact, for papers by Amanda C. Pawlak Breakdown of academic impact, for papers by Marco Brugia Breakdown of academic impact, for papers by Johann Raats
Rankless by CCL
2026